Economic impacts attributable to the early clinical benefit of atorvastatin therapy – a US managed care perspective

Author： Straka Robert J.   Mamdani Muhammad   Damen Joep   Kuntze C. Erik E.   Liu Larry Z.   Botteman Marc F.   Koren Michael J.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.7, 2007-07, pp. : 1517-1529

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study

By Foody JoAnne M.   Joyce Amie T.   Rudolph Amy E.   Liu Larry Z.   Benner Joshua S.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1987-2000

Informa Healthcare

Access to resources Recommend Favorite

Budget impact of rosuvastatin initiation in high-risk hyperlipidemic patients from a US managed care perspective

By Montouchet C.  

Journal of Medical Economics, Vol. 16, Iss. 7, 2013-07 ,pp. : 907-916

Informa Healthcare

Access to resources Recommend Favorite

Clinical Responsibility and Legal Liability in Managed Care

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 3, 1998-03 ,pp. : 373-377

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Ethics of Managed Care: Report on a Congress of Clinical Societies

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 3, 1998-03 ,pp. : 309-313

John Wiley & Sons Inc

Access to resources Recommend Favorite

Economic burden of healthcare-associated infection in US acute care hospitals: societal perspective

By Marchetti Albert   Rossiter Richard  

Journal of Medical Economics, Vol. 16, Iss. 12, 2013-12 ,pp. : 1399-1404

Informa Healthcare

Access to resources Recommend Favorite